Infinity Pharma (INFI) – Upgrades
-
UPDATE: JPMorgan Upgrades Infinity Pharmaceutical (INFI) to Overweight
-
Wells Fargo Upgrades Infinity Pharmaceutical (INFI) to Overweight, Sees Upside to $30
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to INFI Stock Lookup